2m 2m 2m 2m 2m 2m 2m
MYOMO (MYO)
NYSE
$1.07+$0.01 (+0.94%)
Price as of Jun 03, 2026 6:35 PM EDT- $42.1MMarket Cap
- -63.19%1-Year Change
- Medical DevicesIndustry
MYOMO (MYO)
$1.07+$0.01 (+0.94%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 40.9M +25.73% | 32.6M +69.17% | 19.2M +23.70% | 15.6M +12.26% | |
Cost of Revenue | 14.0M +49.90% | 9.4M +54.58% | 6.1M +14.27% | 5.3M +49.60% | |
Gross Profit | 26.9M +15.97% | 23.2M +75.88% | 13.2M +28.57% | 10.3M -0.57% | |
Sales and Marketing Expense | 20.4M +66.59% | 12.2M -34.83% | 18.8M +1.81% | 18.4M +2.33% | |
Research and Development Expense | -6.9M +45.51% | -4.8M +81.00% | -2.6M +6.20% | -2.5M -2.93% | |
Depreciation and Amortization Expense | 859,354 +317.34% | 205,910 +25.32% | 164,306 -14.78% | 192,799 +32.06% | |
Total Operating Expenses | 41.3M +40.48% | 29.4M +37.26% | 21.4M +2.34% | 20.9M +1.68% | |
Operating Profit | -14.4M +132.04% | -6.2M -24.60% | -8.2M -22.87% | -10.7M +3.94% | |
Interest Income | N/A N/A | 169,500 0.00% | 169,500 +354.89% | -66,500 N/A | |
Interest Expense | -450,832 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -450,832 -365.98% | 169,500 0.00% | 169,500 +354.89% | -66,500 -69.61% | |
Total Nonoperating Income and Expense | -667,505 -271.78% | 388,586 +61.92% | 239,986 +1,036.35% | 21,119 +237.71% | |
Income before Taxes | -15.1M +159.01% | -5.8M -27.20% | -8.0M -24.97% | -10.7M +3.58% | |
Income Taxes | 504,532 +37.99% | 365,617 +134.37% | 156,002 +123.06% | 69,937 -21.36% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -15.6M +151.85% | -6.2M -24.10% | -8.1M -24.00% | -10.7M +3.36% | |
Net Income from Continuing Operations Applicable to Common | -15.1M +159.01% | -5.8M -27.20% | -8.0M -25.46% | -10.7M -2.64% | |
Basic EPS and Net Income | -0.37 +131.25% | -0.16 -42.86% | -0.28 -81.58% | -1.52 -19.58% | |
Diluted EPS and Net Income | -0.37 +131.25% | -0.16 -42.86% | -0.28 -81.58% | -1.52 -19.58% | |
Basic Weighted Average Shares | 41.9M +10.85% | 37.8M +28.00% | 29.5M +318.34% | 7.1M +20.94% | |
Diluted Weighted Average Shares | 41.9M +10.85% | 37.8M +28.00% | 29.5M +318.34% | 7.1M +20.94% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 14.1M -42.02% | 24.4M +254.70% | 6.9M +28.53% | 5.3M -65.56% | |
Short-Term Investments | 4.3M +764.48% | 492,990 -75.28% | 2.0M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 18.4M -26.03% | 24.9M +180.46% | 8.9M +65.84% | 5.3M -65.56% | |
Total Current Assets | 27.6M -15.96% | 32.8M +140.20% | 13.7M +48.13% | 9.2M -51.97% | |
Accumulated Depreciation | 1.9M +86.38% | 994,909 +26.10% | 788,999 +24.55% | 633,485 +46.68% | |
Property and Plant and Equipment and Net | 2.2M +66.38% | 1.3M +656.57% | 175,794 -9.52% | 194,283 -29.43% | |
Total Long-Term Assets | 21,374 -87.00% | 164,412 +80.20% | 91,237 -17.83% | 111,034 -59.67% | |
Total Assets | 38.6M -8.54% | 42.2M +189.71% | 14.6M +43.49% | 10.2M -49.43% | |
Income Taxes Payable | 813,260 +155.03% | 318,885 +230.58% | 96,461 +100.04% | 48,220 N/A | |
Total Short-Term Debt | 3.0M +687.96% | 375,000 N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 8.3M -17.96% | 10.2M +85.72% | 5.5M +52.06% | 3.6M -15.91% | |
Total Long-Term Debt | 11.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 18.9M +156.69% | 7.4M +6,289.53% | 115,160 -42.62% | 200,705 +70.00% | |
Total Liabilities | 27.2M +55.35% | 17.5M +213.47% | 5.6M +47.06% | 3.8M -18.86% | |
Retained Earnings | -118.7M +15.10% | -103.1M +6.38% | -96.9M +9.18% | -88.8M +13.73% | |
Total Stockholders Equity | 11.4M -53.86% | 24.7M +174.93% | 9.0M +41.36% | 6.4M -58.73% | |
Total Shares Outstanding | 38.5M +11.91% | 34.4M +26.69% | 27.1M +250.10% | 7.8M +12.82% | |
Cash Flow | |||||
Cash from Operating Activities | -14.5M +341.09% | -3.3M -46.70% | -6.2M -39.68% | -10.2M +7.18% | |
Capital Expenditures | 1.7M +28.09% | 1.4M +832.77% | 145,816 +30.43% | 111,793 -65.76% | |
Cash from Investing Activities | -7.1M -2,814.80% | 259,981 +112.81% | -2.0M +553.03% | -310,793 -4.80% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.4M -45.41% | 20.9M +115.50% | 9.7M +2,477.48% | 376,858 -97.14% | |
Financials Ratio | |||||
Gross Margin | 65.70% -7.76% | 71.23% +3.96% | 68.51% +3.94% | 65.91% -11.43% | |
Operating Margin | -35.19% +84.55% | -19.07% -55.43% | -42.78% -37.64% | -68.61% -7.42% | |
Return on Assets | -38.51% +76.95% | -21.76% -66.95% | -65.86% -7.07% | -70.87% +18.90% | |
Return on Equity | -86.24% +135.02% | -36.69% -65.44% | -106.17% +7.78% | -98.50% +28.08% | |
Revenue Growth | 25.73% -62.80% | 69.17% +191.93% | 23.70% +93.27% | 12.26% -85.18% | |
Current Ratio | 3.30 +2.44% | 3.22 +29.34% | 2.49 -2.58% | 2.56 -42.88% | |
Cash Ratio | 1.69 -29.33% | 2.40 +90.99% | 1.25 -15.47% | 1.48 -59.05% | |
Debt-to-Equity Ratio | 1.24 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.37 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow